MedKoo Cat#: 584850 | Name: Scopafungin malonate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Scopafungin is a crystalline nonpolyenic antimicrobial agent from culture broth of Streptomyces hygroscopicus.

Chemical Structure

Scopafungin malonate
Scopafungin malonate
CAS#116296-63-0 (malonate)

Theoretical Analysis

MedKoo Cat#: 584850

Name: Scopafungin malonate

CAS#: 116296-63-0 (malonate)

Chemical Formula: C62H107N3O22

Exact Mass: 1141.7237

Molecular Weight: 1246.54

Elemental Analysis: C, 59.74; H, 8.65; N, 3.37; O, 28.24

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
11056-18-1 (free base) 116296-63-0 (malonate)
Synonym
Scopafungin; N-29479; U 29479; U-29,479; Scopafungin malonate; Amycin A
IUPAC/Chemical Name
Propanedioic acid, mono(5,7,9,19,23,25,27,31,33,34,35-undecahydroxy-15-(11-((imino(methylamino)methyl)amino)-1,3-dimethyl-7-undecenyl)-8,14,18,22,26,30-hexamethyl-17-oxo-16,37-dioxabicyclo(31.3.1)heptatriaconta-10,12,20-trien-3-yl) ester malonate
InChi Key
HIBYARUCWIEDPI-OZHDXRHSSA-N
InChi Code
InChI=1S/C59H103N3O18.C3H4O4/c1-34(18-14-12-10-11-13-17-25-62-58(60)61-9)26-38(5)55-37(4)19-15-16-20-45(64)39(6)49(68)28-42(63)27-43(78-54(74)32-53(72)73)29-44-30-51(70)56(75)59(77,80-44)33-52(71)36(3)22-23-46(65)40(7)50(69)31-48(67)35(2)21-24-47(66)41(8)57(76)79-55;4-2(5)1-3(6)7/h10-11,15-16,19-21,24,34-52,55-56,63-71,75,77H,12-14,17-18,22-23,25-33H2,1-9H3,(H,72,73)(H3,60,61,62);1H2,(H,4,5)(H,6,7)/b11-10+,19-15-,20-16+,24-21+;
SMILES Code
O=C(OC(CC(O)CC(O)C(C)C(O)/C=C/C=C\C(C)C(C(C)CC(C)CCC/C=C/CCCNC(NC)=N)O1)CC(O2)CC(O)C(O)C2(O)CC(O)C(C)CCC(O)C(C)C(O)CC(O)C(C)/C=C/C(O)C(C)C1=O)CC(O)=O.O=C(O)CC(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,246.54 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Johnson LE, Dietz A. Scopafungin, a crystalline antibiotic produced by Streptomyces hygroscopicus var. enhygrus var. nova. Appl Microbiol. 1971 Sep;22(3):303-8. PubMed PMID: 4940870; PubMed Central PMCID: PMC376304. 2: Bergy ME, Hoeksema H. Scopafungin, a crystalline endomycin component. J Antibiot (Tokyo). 1972 Jan;25(1):39-43. PubMed PMID: 5010644. 3: Takesako K, Nakamura T, Obayashi A, Iwasaki S, Namikoshi M, Okuda S, Beppu T. Demalonyl derivatives of azalomycin F4 and scopafungin. J Antibiot (Tokyo). 1986 May;39(5):713-6. PubMed PMID: 3733520. 4: Reusser F. Scopafungin, an inhibitor of oxidative phosphorylation in mitochondria. Biochem Pharmacol. 1972 Apr 1;21(7):1031-8. PubMed PMID: 4339110. 5: Mogi T, Matsushita K, Murase Y, Kawahara K, Miyoshi H, Ui H, Shiomi K, Omura S, Kita K. Identification of new inhibitors for alternative NADH dehydrogenase (NDH-II). FEMS Microbiol Lett. 2009 Feb;291(2):157-61. doi: 10.1111/j.1574-6968.2008.01451.x. Epub 2008 Dec 5. PubMed PMID: 19076229. 6: Stefanelli S, Corti E, Montanini N, Denaro M, Sarubbi E. Inhibitors of type-I interleukin-1 receptor from microbial metabolites. J Antibiot (Tokyo). 1997 Jun;50(6):484-9. PubMed PMID: 9268004. 7: Kumazawa S, Asami Y, Awane K, Ohtani H, Fukuchi C, Mikawa T, Hayase T. Structural studies of new macrolide antibiotics, shurimycins A and B. J Antibiot (Tokyo). 1994 Jun;47(6):688-96. PubMed PMID: 8040074. 8: Dolak LA, Reusser F, Baczynskyj L, Mizsak SA, Hannon BR, Castle TM. Desertomycin: purification and physical-chemical properties. J Antibiot (Tokyo). 1983 Jan;36(1):13-9. PubMed PMID: 6678910. 9: Kuimova TF, Kazakov GA, Inshakova TA. [Spontaneous crystallization of antibiotic substance during submerged fermentation of Actinomyces hygroscopicus]. Mikrobiologiia. 1976 JUL-AUG;45(4):746-9. Russian. PubMed PMID: 979694.